Babelon Investments Company (P.L.C) (ASE:SALM)

Ligand Pharmaceuticals Revenue

Babelon Investments Company (P.L.C) had revenue of 104.89K JOD in the quarter ending June 30, 2025, with 15.59% growth. This brings the company's revenue in the last twelve months to 130.35K, up 10.88% year-over-year. In the year 2024, Babelon Investments Company (P.L.C) had annual revenue of 117.03K, down -35.99%.

• Revenue (ttm): 130.35K
• Revenue Growth: +10.88%
• P/S Ratio: 14.73
• Revenue / Employee: 130.35K
• Employees: 1
• Market Cap: 1.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	117.03K	-65.79K	-35.99%
Dec 31, 2023	182.82K	91.48K	100.14%
Dec 31, 2022	91.35K	43.71K	91.74%
Dec 31, 2021	47.64K	-67.69K	-58.69%
Dec 31, 2020	115.33K	-5.27K	-4.37%